Viz.ai joins the ranks of distinguished businesses that are paving the way for innovations of tomorrow on Fast Company’s World’s Most Innovative Companies list for 2024

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has been named to Fast Company’s Most Innovative Companies for 2024. The prestigious annual list recognizes the world’s most groundbreaking companies at the forefront of their respective industries. Viz.ai was chosen from renowned companies across the globe for this list, which is widely recognized as a preeminent honor a business may receive for its novel ideas or approach to radically transform an industry or sector.

“This award speaks volumes about the real-world impact we have already made toward improving patient outcomes with our innovative approach to harnessing the power of artificial intelligence,” said Chris Mansi, MD, CEO and co-founder at Viz.ai. “Our AI-powered care coordination solution is leading the charge to streamline the way patient care is delivered, provide relevant clinical insights, and inform critical decisions at the point of care. We are honored to be recognized as one of the World’s Most Innovative Companies by Fast Company and look forward to continuing to drive meaningful change in healthcare and life sciences by improving patient access to life-saving treatments and outcomes.”

Viz.ai develops and deploys its Viz.ai One platform across its vast footprint to streamline patient journeys and accelerate speed to diagnosis and therapy. Viz.ai was granted the first de novo approval by the FDA for AI computer-aided triage in 2018 and again in 2023 for cardiovascular machine learning-based notification software. In January 2024, the company surpassed adoption in 1,500 hospitals in the United States, including the majority of the 50 largest healthcare systems. It also works with 7 of the top 30 global life science companies.

Viz.ai One integrates with electronic health records (EHRs) and radiology worklist systems to empower multidisciplinary care teams and help coordinate care across workflows. With more than 100 clinical abstracts and publications, Viz.ai continues to demonstrate significant real-world evidence on the patient and economic outcomes of AI-powered care coordination.

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,500+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One^TM is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240319660000/en/